CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 15, 2006--Biogen Idec Inc. (NASDAQ: BIIB), a global biotechnology leader with leading products and capabilities in oncology, neurology and immunology, today reported its full year 2005 and fourth quarter results.
